Integrated Investment Consultants’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,534
| Closed | -$260K | – | 324 |
|
|
2025
Q1 | $260K | Sell |
3,534
-500
| -12% | -$36.8K | 0.05% | 272 |
|
|
2024
Q4 | $264K | Sell |
4,034
-284
| -7% | -$18.6K | 0.05% | 251 |
|
|
2024
Q3 | $336K | Buy |
+4,318
| New | +$336K | 0.07% | 212 |
|
|
2023
Q2 | – | Sell |
-8,856
| Closed | -$615K | – | 271 |
|
|
2023
Q1 | $615K | Sell |
8,856
-1,217
| -12% | -$84.5K | 0.19% | 83 |
|
|
2022
Q4 | $683K | Buy |
10,073
+147
| +1% | +$9.97K | 0.23% | 66 |
|
|
2022
Q3 | $545K | Sell |
9,926
-260
| -3% | -$14.3K | 0.22% | 72 |
|
|
2022
Q2 | $672K | Sell |
10,186
-4,620
| -31% | -$305K | 0.24% | 63 |
|
|
2022
Q1 | $982K | Sell |
14,806
-1,928
| -12% | -$128K | 0.27% | 58 |
|
|
2021
Q4 | $976K | Hold |
16,734
| – | – | 0.26% | 62 |
|
|
2021
Q3 | $1.01M | Buy |
16,734
+250
| +2% | +$15K | 0.29% | 56 |
|
|
2021
Q2 | $988K | Buy |
16,484
+7,060
| +75% | +$423K | 0.29% | 56 |
|
|
2021
Q1 | $468K | Sell |
9,424
-1,120
| -11% | -$55.6K | 0.16% | 118 |
|
|
2020
Q4 | $527K | Buy |
10,544
+900
| +9% | +$45K | 0.2% | 91 |
|
|
2020
Q3 | $528K | Buy |
9,644
+987
| +11% | +$54K | 0.25% | 78 |
|
|
2020
Q2 | $458K | Sell |
8,657
-1,580
| -15% | -$83.6K | 0.22% | 76 |
|
|
2020
Q1 | $457K | Buy |
10,237
+2,091
| +26% | +$93.3K | 0.27% | 67 |
|
|
2019
Q4 | $406K | Buy |
8,146
+1,493
| +22% | +$74.4K | 0.17% | 92 |
|
|
2019
Q3 | $296K | Buy |
+6,653
| New | +$296K | 0.15% | 104 |
|
|
2018
Q2 | – | Sell |
-404
| Closed | -$14K | – | 210 |
|
|
2018
Q1 | $14K | Buy |
+404
| New | +$14K | 0.01% | 584 |
|
|
2016
Q4 | – | Sell |
-2,953
| Closed | -$91K | – | 579 |
|
|
2016
Q3 | $91K | Sell |
2,953
-1,803
| -38% | -$55.6K | 0.05% | 287 |
|
|
2016
Q2 | $144K | Buy |
4,756
+275
| +6% | +$8.33K | 0.08% | 187 |
|
|
2016
Q1 | $132K | Buy |
+4,481
| New | +$132K | 0.08% | 175 |
|